Macrophage-Targeting DNA Nanomaterials: A Future Direction of Biological Therapy
DOI: https://doi.org/10.2147/ijn.s459288
IF: 7.033
2024-04-23
International Journal of Nanomedicine
Abstract:Yu-Chi Tu, &ast Yu-Mei Wang, &ast Li-Jun Yao Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Li-Jun Yao, Email DNA can be used for precise construction of complex and flexible micro-nanostructures, including DNA origami, frame nucleic acids, and DNA hydrogels. DNA nanomaterials have good biocompatibility and can enter macrophages via scavenger receptor-mediated endocytosis. DNA nanomaterials can be uniquely and flexibly designed to ensure efficient uptake by macrophages, which represents a novel strategy to regulate macrophage function. With the development of nanotechnology, major advances have been made in the design and manufacturing of DNA nanomaterials for clinical therapy. In diseases accompanied by macrophage disturbances including tumor, infectious diseases, arthritis, fibrosis, acute lung injury, and atherosclerosis, DNA nanomaterials received considerable attention as potential treatments. However, we lack sufficient information to guarantee precise targeting of macrophages by DNA nanomaterials, which precludes their therapeutic applications. In this review, we summarize recent studies of macrophage-targeting DNA nanomaterials and discuss the limitations and challenges of this approach with regard to its potential use as a biological therapy. Keywords: macrophages, DNA nanomaterials, therapy, macrophage-related diseases Macrophages are abundant immune cells that differentiate from monocytes and play a vital role in immune responses. Macrophages specifically recognize targets through different surface receptors, and this recognition is necessary for their phagocytic function. 1 Phagocytosis by macrophages is a key innate immune system mechanism to remove pathogens, microorganisms, and harmful foreign particles from the body. 2 Macrophages also present antigens to recruit and activate other immune cells (such as T and NK cells) to initiate adaptive immunity processes. 3 In addition to their involvement in immune responses, macrophages also regulate inflammatory reactions. Depending on the local environment, macrophages acquire different activation states. Traditionally, they are mainly divided into a "classically activated" phenotype (also referred to as M1) and an "alternatively activated" phenotype (also referred to as M2). Under stimulation with IFN-γ and lipopolysaccharide(LPS), macrophages mainly present the M1 macrophage phenotype (characterized by MHC-II and costimulatory molecules such as CD40, CD81, CD86, and intracellular iNOS expression), known as "classically activated" phenotype. CD68 + M1 macrophages promote inflammatory responses through the secretion of pro-inflammatory factors, such as tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and IL-12. Under stimulation with IL-4 and IL-13, macrophages present the M2 macrophage phenotype (characterized by CD206, CD163, arginase-1 expression), also known as "alternatively activated" phenotype. The anti-inflammatory effect of CD206 + M2 macrophages is mediated by the secretion of anti-inflammatory cytokines, such as transforming growth factor β (TGF-β) and IL-10, which inhibit inflammation. 4 Changes in macrophage polarization phenotype occur in many pathological states and play an important role in cancer, fibrosis, and infectious diseases. 5,6 Therefore, the regulation of macrophage function is an essential target for the treatment of diseases accompanied by disturbances of macrophage properties. DNA nanomaterials with flexible structures and high biocompatibility are an emerging nanotechnology that can be used to target macrophages. DNA nanomaterials can be engineered to enter macrophages through scavenger receptor-mediated endocytosis, 7 and various structural surface and shape modifications can increase the rate of uptake of these substances by macrophages. 8,9 Unlike conventional nanomaterials, 10 DNA nanomaterials are not overly toxic and have minor side effects and good biological safety after the internalization by macrophages. 11 These properties provide a unique advantage for macrophage targeting. The high loading capacity of DNA nanomaterials is also a useful feature that can be exploited when creating therapeutic agents targeting macrophages. In this review, we provide a brief overview of the biological functions of macrophages in diseases, describe different types of DNA nanostructures, and consider the necessary characteristics of macrophage-targeting DNA nanomaterials. Next, we discuss the regulation of macrophages by DNA nanomaterials and their possible applications in various diseases. Macrophages a -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology